Lisata Therapeutics, Inc.

LSTA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0000320017

SEC filings (opens in a new tab)

No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $3.70M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Lisata Therapeutics, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of LSTA: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Q4 2023	Change
Holders	21	22	+1
Shares	684.8K	742.1K	+57.3K (+8.4%)
Value	$1.46M	$2.03M	+$564.9K (+38.7%)

New holders (2)

Institutions that held Lisata Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to LSTA in Q4 2023
Institution	Shares	Value	% of portfolio
Susquehanna International Group, LLP	33,749	$92.1K	0.00%
Tower Research Capital LLC (TRC)	1,029	$2.81K	0.00%

Sold out (1)

Institutions that held Lisata Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of LSTA in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
IFP Advisors, Inc	10	$21